Results for Cholangiocarcinoma

Rss Feed: Click here

These results suggest fisetin in combination with gemcitabine as a candidate for use in improved anticancer regimens.

Article Published Date : Jan 10, 2016

Study Type : In Vitro Study

Additional Links

Substances : Fisetin : CK(173) : AC(112), Flavonoids : CK(1616) : AC(523)

Diseases : Cholangiocarcinoma : CK(96) : AC(21)

Pharmacological Actions : Antiproliferative : CK(4773) : AC(3450), Apoptotic : CK(5217) : AC(3846), Chemotherapeutic : CK(397) : AC(152)

Additional Keywords : Antiproliferative : CK(65) : AC(52), Apoptotic, Chemotherapeutic, Chemotherapeutic Synergy: Gemcitabine : CK(39) : AC(29), Cholangiocarcinoma, Fisetin, Flavonoids

Click here to view the entire abstract

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.